← Every company
Jazz Pharmaceuticals PLC Patents
What Jazz Pharmaceuticals PLC has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
JAZZ on carbonthat →Filings on file
54
Granted
3
Still pending
51
Filed under
13 names
54 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| CANNABIDIOL PREPARATIONS AND ITS USESA61K 31/658, A61K 45/06, A61P 25/28, A61P 25/30, A61P 25/10, A61P 25/32, A61P 25/12, A61P 25/18, A61P 25/00, A61P 25/08, A61P 25/16, A61K 36/3482, A61K 9/0019, A61K 9/0053, A61K 9/0073, A61K 9/7023, A61K2236/33, A61K2236/51, B01D 9/0013, B01D 11/0203, B01D 11/0288, A61K2300/00Filed as Jazz Pharmaceuticals Research UK Limited2026-05-26Geoffrey GUY | pending |
| USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSYA61K 31/658, A61P 25/08, A61K 31/522, A61K 36/185, A61K 31/05, A61K2300/00Filed as Jazz Pharmaceuticals Research UK Limited2026-05-06Jie LI | pending |
| RAS INHIBITORS AND METHODS OF USING THE SAMEC07D 401/14, C07D 403/12, A61P 31/00, C07D 239/42, C07D 239/47, C07D 239/48, C07D 401/04, C07D 403/04, C07D 403/14, C07D 413/14, C07D 487/08Filed as Jazz Pharmaceuticals Ireland Limited2026-04-21Andrew BELFIELD | pending |
| USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSYA61K 31/658, A61P 25/08, A61K 36/3482, A61K 31/165, A61K 31/22, A61K 31/27, A61K 31/357, A61K 31/4015, A61K 31/55, A61K 31/5513, A61K 36/00, A61K 36/185, A61K 45/06, A61K 31/352, A61K2300/00Filed as Jazz Pharmaceuticals Research UK Limited2026-04-20Geoffrey GUY | pending |
| PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR THE TREATMENT OF PCPG: PHEOCHROMOCYTOMAS AND PARAGANGLIOMASFiled as JAZZ PHARMACEUTICALS IRELAND LIMITED2026-03-27VARUN VIJAY PRABHU | pending |
| ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDSA61K 31/658, A61K 9/143, A61K 9/0053, A61K 9/1611, A61K 9/1617, A61K 9/4866, A61K 47/02, A61K 47/22, A61K 47/26, A61K 47/36, A61K 47/38Filed as Jazz Pharmaceuticals Research UK Limited2026-03-10Jonathon Oliver WHITEHOUSE | pending |
| SODIUM OXYBATE TO TREAT IDIOPATHIC HYPERSOMNIAA61K 31/19, A61P 25/20, A61P 25/00Filed as Jazz Pharmaceuticals Ireland Limited2026-02-25Franck SKOBIERANDA | pending |
| GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERSA61K 31/19, A61P 25/00, A61K2300/00Filed as Jazz Pharmaceuticals Ireland Limited2026-02-25Clark P. ALLPHIN | pending |
| GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISORDERSA61K 31/19, A61P 25/20, A61P 25/04, A61P 25/00, A61K 9/0053, A61K 9/08, A61K 31/554, A61K2300/00Filed as Jazz Pharmaceuticals Ireland Limited2026-02-23Clark P. ALLPHIN | pending |
| DOSING AND ADMINISTRATION OF RECOMBINANT L-ASPARAGINASEA61K 38/50, A61K 47/60, A61P 35/02, Y02A 50/30, A61P 35/00, A61K 9/0019, A61K 45/06, C12Y 305/01001Filed as Jazz Pharmaceuticals Ireland Ltd.2026-02-12Mi Rim Choi | pending |
| METHOD OF PREPARING CANNABINOIDSA61K 31/05, B01D 9/00, B01D 11/0288, B01D 11/0492, A61K 36/3482, A61K 36/185, A61K2236/00, A61K2236/30, A61K2236/53, A61K2236/55, B01D 9/0013, B01D 9/0036, B01D 9/0045, B01D 11/00, B01D 11/0203, B01D 11/028, C07C 39/23Filed as Jazz Pharmaceuticals Research UK Limited2025-12-24Michael Simon LOFT | pending |
| Methods of Treating Pheochromocytoma and ParagangliomaFiled as Jazz Pharmaceuticals Ireland Limited2025-11-24Joshua Edward ALLEN | pending |
| METHODS OF USE OF A LIPOSOMAL COMPOSITION COMPRISING AN ATR INHIBITORA61K 31/4965, A61P 35/00, A61K 33/243, A61K 9/127, A61K 31/282, A61K 31/4745, A61K 31/497, A61K 31/7068Filed as Jazz Pharmaceuticals Therapeutics, Inc.2025-11-19Leon WAN | pending |
| PYRAZOLO[4,3-F]QUINAZOLINE DERIVATIVES AS MODULATORS OF G12D MUTANT KRAS USEFUL FOR THE TREATMENT OF CANCERC07D 487/04, A61K 31/519, A61K 31/5377, A61K 31/5386, A61K 31/55, A61K 31/551, A61K 31/553, C07D 519/00Filed as JAZZ PHARMACEUTICALS IRELAND LTD.2025-11-12Inder BHAMRA | pending |
| ANTICONVULSIVE COMPOUNDS AND USES THEREOFC07D 471/04, A61P 25/08, A61K 31/437Filed as Jazz Pharmaceuticals Research UK Limite2025-11-11Paolo DI FRUSCIA | pending |
| Cannabidiol Solid Dosage FormsA61K 31/658, A61K 9/143, A61K 9/0053, A61K 9/1617, A61K 9/1623, A61K 9/1635, A61K 9/1641, A61K 9/1652, A61K 47/02, A61K 47/26, A61K 47/36, A61K 47/38Filed as Jazz Pharmaceuticals Research UK Limited2025-10-30Jonathon Oliver WHITEHOUSE | pending |
| LIPOSOMAL FORMULATIONS OF BCL INHIBITORSA61K 9/1272, A61K 9/1277, A61K 31/635, A61P 7/04, A61P 35/02, A61P 35/00, A61K 9/127, A61K 9/1271, A61K 31/12, A61K 31/496, A61K 45/06, A61K 47/02, A61K 47/186, A61K 47/20, A61K 47/24, A61K 47/26, A61K 47/28, A61K2300/00Filed as Jazz Pharmaceuticals Therapeutics, Inc.2025-09-30Paul TARDI | pending |
| USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSYA61K 31/658, A61P 25/08, A61K 36/3482, A61K 31/165, A61K 31/22, A61K 31/27, A61K 31/357, A61K 31/4015, A61K 31/55, A61K 31/5513, A61K 36/00, A61K 36/185, A61K 45/06, A61K 31/352, A61K2300/00Filed as Jazz Pharmaceuticals Research UK Limited2025-08-25Geoffrey GUY | pending |
| METHODS OF TREATING SOLID TUMORS WITH MITOGEN ACTIVATED PROTEIN KINASE (MAPK) PATHWAY ALTERATIONSA61K 31/4375, A61P 35/04, A61P 35/00Filed as Jazz Pharmaceuticals Ireland Limited2025-08-15Ronald CHEUNG | pending |
| MACROCYCLIC OREXIN RECEPTOR AGONISTS AND USES THEREOFFiled as Jazz Pharmaceuticals Ireland Limited2025-07-30Prafulkumar CHOVATIA | pending |
| CANNABIDIOL-TYPE CANNABINOID COMPOUNDA61K 31/658, A61P 25/08, A61K 36/3482, C07C 37/68, C07C 39/23Filed as Jazz Pharmaceuticals Research UK Limited2025-07-24Geoffrey GUY | pending |
| CHIRAL SYNTHESIS OF FUSED BICYCLIC RAF INHIBITORSC07D 471/04, A61P 35/00, A61K 31/4375, A61K 31/4439, A61K 31/444, A61K 31/506, A61K 45/06, B01J 31/22, B01J 31/2409, B01J2531/821, C07B2200/07, C07D 405/04, C07D 405/14Filed as Jazz Pharmaceuticals Ireland Limited2025-07-14Andrew BELFIELD | pending |
| LOW-INTENSITY TREATMENT OF HEMATOLOGICAL DISORDERSA61K 31/7068, A61K 45/06, A61P 35/02, A61K 9/0019, A61K 9/127, A61K 31/496, A61K 31/53, A61K 31/553, A61K 31/635, A61K 31/704, A61K 39/3955, A61K2300/00Filed as Jazz Pharmaceuticals Therapeutics, Inc.2025-06-24Ronald CHEUNG | pending |
| CANNABIDIOL-TYPE CANNABINOID COMPOUNDA61K 31/658, C07C2601/16, A61P 25/08, C07C 39/23Filed as JAZZ PHARMACEUTICALS RESEARCH UK LIMITED2025-06-20Geoffrey GUY | pending |
| CANNABINOIDS FOR TREATING ESSENTIAL TREMOR IN PATIENTSA61K 31/658, A61P 25/14, A61P 21/00, A61K 31/015, A61K 31/045, A61K 31/355, A61K 31/575, A61K 45/06, A61K2300/00Filed as Jazz Pharmaceuticals Research UK Limited2025-06-02Andrew C. MCCREARY | pending |
| CRYSTALLINE FORMS OF (S)-5-((3-(4-(4-FLUOROPHENYL)-1H-IMIDAZOL-2-YL)CHROMAN-6-YL)OXY)-3,4-DIHYDRO-1,8-NAPHTHYRIDIN-2(1H)-ONEC07D 471/04, A61P 35/00, A61K 31/4375, C07B2200/13Filed as Jazz Pharmaceuticals Ireland Limited2025-05-28Adrian COOGAN | pending |
| ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDSA61K 31/658, A61K 9/143, A61K 9/0053, A61K 9/1611, A61K 9/1617, A61K 9/4866, A61K 47/02, A61K 47/22, A61K 47/26, A61K 47/36, A61K 47/38Filed as JAZZ PHARMACEUTICALS RESEARCH UK LIMITED2025-05-16Jonathon Oliver WHITEHOUSE | 12569505 |
| FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOFC07D 471/04, A61P 35/02, A61P 35/00, A61K 31/4375, A61K 31/4439, A61K 31/4725, A61K 45/06, C07D 405/14, C07D 417/14, C07D 519/00Filed as Jazz Pharmaceuticals Ireland Limited2025-05-12Andrew BELFIELD | pending |
| USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSYA61K 31/658, A61P 43/00, A61P 25/00, A61P 25/08, A61K 9/08, A61K 36/185, A61K 45/06, A61K 47/10, A61K2300/00, A61K 31/05Filed as Jazz Pharmaceuticals Research UK Limited2025-04-23Geoffrey GUY | 12427160 |
| DEFIBROTIDE FOR USE IN PREVENTING AND TREATING SEPSISA61K 31/711, A61P 31/04, A61K 9/0019Filed as JAZZ PHARMACEUTICALS IRELAND LIMITED2025-04-23Ju SHI | pending |
| SUBSTITUTED HETEROCYCLES AS RAS INHIBITORSA61K 31/4178, C07D 403/14, A61P 35/00, A61K 31/423, A61K 31/427, A61K 31/4439, A61K 31/5377, C07D 401/14, C07D 403/04, C07D 409/14, C07D 413/14, C07D 417/14Filed as Jazz Pharmaceuticals Ireland Limited2025-02-26Clifford D. JONES | pending |
| CANNABIDIOL COMPOSITIONS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE AND NEUROLOGICAL DISORDERSA61P 25/28, A61K 31/658, A61P 25/14, A61P 25/20, A61P 25/22, A61P 25/18, A61P 25/24, A61P 25/00, A61K 9/0019, A61K 9/0053, A61K 45/06Filed as JAZZ PHARMACEUTICALS RESEARCH UK LIMITED2025-02-10Benjamin WHALLEY | pending |
| USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSYA61K 31/658, A61P 43/00, A61P 11/00, A61P 25/08, A61K 36/3482, A61K 9/0095, A61K 45/06, A61K 31/352, A61K2300/00Filed as Jazz Pharmaceuticals Research UK Limited2025-01-16Geoffrey GUY | pending |
| COMBINATION THERAPIES INVOLVING L-ASPARAGINASEA61P 35/00, C12N 9/82, A61P 35/02, A61K 31/055, A61K 31/166, A61K 31/351, A61K 31/352, A61K 31/365, A61K 31/366, A61K 31/404, A61K 31/426, A61K 31/428, A61K 31/436, A61K 31/439, A61K 31/444, A61K 31/4725, A61K 31/4741, A61K 31/501, A61K 31/519, A61K 31/566, A61K 31/57, A61K 31/585, A61K 31/635, A61K 31/712, A61K 38/50, A61K 45/06, A61K2300/00, C12Y 305/01001, A61K 31/5377, A61K 31/4184, A61K 31/69, A61K 31/505, A61K 31/704, A61K 31/573, A61K 31/475, A61K 31/675Filed as Jazz Pharmaceuticals Ireland Ltd.2024-12-31Hemamalini Gursahani | pending |
| CRYSTALINE FORMS OF A SYNTHETIC CANNABINOIDC07D 231/12, A61P 25/08, A61K 31/415Filed as Jazz Pharmaceuticals Research UK Limited2024-12-12Hannah E. STRAKER | pending |
| MACROCYCLIC OREXIN RECEPTOR AGONISTS AND USES THEREOFA61P 25/00, C07D 498/20, A61K 31/439, A61K 31/537, A61K 31/5386, A61K 31/547, C07D 471/20, C07D 498/22, C07D 513/20Filed as Jazz Pharmaceuticals Ireland Limited2024-11-27Claudia BEATO | pending |
| METHODS OF TREATING IDIOPATHIC HYPERSOMNIAA61K 31/19, A61P 25/00, A61K 9/08Filed as Jazz Pharmaceuticals Ireland Limited2024-11-18Franck Skobieranda | pending |
| INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)A61K 31/4965, A61K 31/497, C07D 403/12, C07D 413/04, A61P 35/00, A61K 9/127, A61K 9/1271, A61K 31/4745, A61K 31/496, A61K 31/555, A61K 31/7068, A61K 47/10, A61K 47/14, A61K 47/24, A61K 47/28, A61K2300/00Filed as Jazz Pharmaceuticals Therapeutics, Inc.2024-11-07Daryl C. DRUMMOND | pending |
| TREATMENT OF SPASTICITY AND PAIN IN RENALLY-IMPAIRED PATIENTSA61K 31/658, A61K 9/006, A61P 43/00, A61P 13/12, A61P 25/00, A61P 29/00, A61P 35/00, A61K 36/3482, A61K 9/08, A61K 9/12, A61K 47/10, A61K2300/00Filed as Jazz Pharmaceuticals Research UK Limited.2024-10-23Cuiping CHEN | pending |
| USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSYFiled as Jazz Pharmaceuticals Research UK Limited2024-10-21Geoffrey GUY | pending |
| RECOMBINANT L-ASPARAGINASEA61K 38/50, A61P 35/02, Y02A 50/30, A61P 1/00, A61K 9/0019, C12Y 305/01001Filed as Jazz Pharmaceuticals Ireland Ltd.2024-10-14Mi Rim Choi | pending |
| USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSYA61K 31/658, A61K 36/185, A61P 25/08, A61K 31/065, A61K 36/00, A61K 45/06, A61K 47/10, A61K 47/26, A61K 47/44, A61K 47/46Filed as Jazz Pharmaceuticals Research UK Limited2024-10-10Geoffrey GUY | pending |
| METHODS OF TREATING IDIOPATHIC HYPERSOMNIAFiled as Jazz Pharmaceuticals Ireland Limited2024-10-07Franck SKOBIERANDA | pending |
| TRICYCLIC PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORSC07D 487/04, A61K 31/5025, A61K 31/506, A61K 31/5383, A61K 31/553, C07D 491/20, C07D 498/04Filed as Jazz Pharmaceuticals Ireland Limited2024-09-20Clifford David JONES | pending |
| REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLESA61K 31/7048, A61K 9/127, A61K 9/1271, A61K 9/1277, A61K 9/19, A61K 31/337, A61K 31/395, A61K 31/4196, A61K 31/496, A61K 31/704, A61K 38/07, A61K 47/02Filed as Jazz Pharmaceuticals Therapeutics, Inc.2024-08-01Mark E. Hayes | pending |
| COMBINATIONS COMPRISING AN ATR INHIBITOR AND A PARP INHIBITOR AND METHODS OF USE THEREOFFiled as JAZZ PHARMACEUTICALS THERAPEUTICS, INC.2024-07-12LEON WAN | pending |
| METHODS OF USE OF A LIPOSOMAL COMPOSITION COMPRISING AN ATR INHIBITORFiled as JAZZ PHARMACEUTICALS THERAPEUTICS , INC.2024-07-12LEON WAN | pending |
| METHOD OF ADMINISTERING OXYBATEA61K 31/19Filed as Jazz Pharmaceuticals Ireland Limited2024-07-10Franck SKOBIERANDA | pending |
| NOVEL AMINE-SUBSTITUTED PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORSC07D 471/04, A61K 31/502, A61P 35/00Filed as Jazz Pharmaceuticals Ireland Limited2024-07-10Clifford David JONES | pending |
| USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSYA61K 31/658, A61P 43/00, A61P 25/10, A61P 25/12, A61P 25/08, A61K 36/3482, A61K 31/5513, A61K 45/06, A61K 47/10, A61K 47/26, A61K 47/44, B01D 9/0013, B01D 11/0203, B01D 11/0288, A61K 31/352, A61K2300/00, A61K 31/05Filed as Jazz Pharmaceuticals Reseach UK Limited2024-07-02Geoffrey GUY | pending |
| GHB DOSINGA61K 31/19, A61P 25/00, A61P 25/08, A61K 9/0053Filed as JAZZ PHARMACEUTICALS IRELAND LIMITED2024-05-01Franck SKOBIERANDA | pending |
| TREATMENT OF HEMATOLOGICAL DISORDERSA61K 31/7068, A61P 35/02, A61K 9/127, A61K 31/635, A61K 31/704Filed as Jazz Pharmaceuticals Ireland Limited2024-04-10Stefan FADERL | 12642811 |
| METHOD OF ADMINISTERING OXYBATEA61K 31/19, A61P 5/00, A61P 25/00Filed as Jazz Pharmaceuticals Ireland Limited2024-04-08Franck SKOBIERANDA | pending |
| INTERFERON PRODRUGSFiled as JAZZ PHARMACEUTICALS IRELAND LIMITED2024-03-14JOSE ANDRES SALMERON-GARCIA | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on JAZZ
Company overviewEverything on JAZZ in one place, with the price.SEC filingsWhat JAZZ's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat JAZZ's own officers and directors buy and sell.Planned salesSales JAZZ insiders have filed notice of.Executive payWhat JAZZ awarded its chief executive, and what it became.LobbyingWhat JAZZ spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on JAZZ's account, and who they worked for.Federal contractsWhat federal agencies pay JAZZ.